ylliX - Online Advertising Network
Press Release

Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics

Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Roche Holding AG (OTC: RHHBY) raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, driven by demand for COVID-19 tests and the strong performance in the broader business. Group sales in the nine months to September rose to CHF46.68 billion from CHF43.98 billion, as diagnostics division sales jumped 39%.

...read full article on Benzinga

ylliX - Online Advertising Network